Wednesday, June 27, 2012

Irish drug price cut deal enables new product listings


The Irish government and the country's drugmakers have agreed interim drug price cuts which, they say, will deliver savings totalling 20 million euros in a full year and allow new products to be supplied through state drug schemes.

The new agreement extends the recently-expired deal between Ireland's Health Service Executive (HSE) and the Irish Pharmaceutical Healthcare Association (IPHA), under which, when a generic equivalent of an off-patent drug came onto the market, the price of the original product was reduced by 20% immediately and by a further 15% after 22 months.

Posted via email from Jack's posterous

No comments: